Assessment of Infant Exposure to Antidepressants through Breastfeeding: A Literature Review of Currently Available Approaches
- PMID: 39065544
- PMCID: PMC11280233
- DOI: 10.3390/pharmaceutics16070847
Assessment of Infant Exposure to Antidepressants through Breastfeeding: A Literature Review of Currently Available Approaches
Abstract
Despite the prevalence of depression in lactating mothers, there is a lack of knowledge about the excretion of antidepressants into breast milk and its potential adverse effects on infants. This creates concern, making depressed lactating mothers more likely to avoid pharmacological treatment. Clinical lactation studies are the most accurate and direct method to predict and demonstrate the excretion of antidepressants into human breast milk, and results from clinical studies can be included in drug labels to help physicians and patients make decisions on antidepressant use during lactation. However, there are limited clinical trials and studies on the pharmacokinetics of antidepressants in lactating women because of a lack of enrollment and ethical and confounding factors, creating a lack of knowledge in this area. To bridge this gap in knowledge, alternative methods should be sought to help estimate the antidepressant concentration in breast milk, which is used to assess the safety and transfer of antidepressants into breast milk. We provide a comprehensive review of the usage of these cost-effective, time-efficient, and ethically feasible methods that serve to provide a valuable estimation of the safety and transfer of antidepressants into breast milk before conducting clinical studies.
Keywords: M/P ratio; antidepressants; breastfeeding; depression; lactation; nursing infant.
Conflict of interest statement
Author Zou P is an employee of Daiichi Sankyo Inc. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Oral galactagogues (natural therapies or drugs) for increasing breast milk production in mothers of non-hospitalised term infants.Cochrane Database Syst Rev. 2020 May 18;5(5):CD011505. doi: 10.1002/14651858.CD011505.pub2. Cochrane Database Syst Rev. 2020. PMID: 32421208 Free PMC article.
-
Pharmacokinetics, Placental and Breast Milk Transfer of Antiretroviral Drugs in Pregnant and Lactating Women Living with HIV.Curr Pharm Des. 2019;25(5):556-576. doi: 10.2174/1381612825666190320162507. Curr Pharm Des. 2019. PMID: 30894103 Review.
-
Antidepressant Treatment of Depression During Pregnancy and the Postpartum Period.Evid Rep Technol Assess (Full Rep). 2014 Jul;(216):1-308. doi: 10.23970/AHRQEPCERTA216. Evid Rep Technol Assess (Full Rep). 2014. PMID: 30313002 Review.
-
Drug excretion into breast milk--overview.Adv Drug Deliv Rev. 2003 Apr 29;55(5):617-27. doi: 10.1016/s0169-409x(03)00034-6. Adv Drug Deliv Rev. 2003. PMID: 12706545 Review.
-
Antidepressants in breast milk; comparative analysis of excretion ratios.Arch Womens Ment Health. 2019 Jun;22(3):383-390. doi: 10.1007/s00737-018-0905-3. Epub 2018 Aug 16. Arch Womens Ment Health. 2019. PMID: 30116895
Cited by
-
Advances in Psychotropic Treatment for Pregnant Women: Efficacy, Adverse Outcomes, and Therapeutic Monitoring.J Clin Med. 2024 Jul 27;13(15):4398. doi: 10.3390/jcm13154398. J Clin Med. 2024. PMID: 39124665 Free PMC article. Review.
-
Machine learning approaches for assessing medication transfer to human breast milk.J Pharmacokinet Pharmacodyn. 2025 Apr 16;52(3):25. doi: 10.1007/s10928-025-09972-9. J Pharmacokinet Pharmacodyn. 2025. PMID: 40240653
References
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous